Effectiveness of treatment

Previously, the recommended method for treating eyelid inflammation was to clean the eyelid with an ear cleansing cotton swab moistened with baby shampoo. Because it is difficult to perform in practice, cotton swab cleaning has not been shown to be a sufficiently effective method to treat chronic dry eye complaints.

Based on clinical trials, it is more effective to alleviate dry eye complaints by cleaning the area around the edges of the eyelids with a special wipe developed for the care of eyelids.

In the case of severe eyelid inflammation, antibiotic and anti-inflammatory treatment may be required temporarily. However, effective treatment and long-term success is crucially dependent on maintaining adequate eyelid hygiene.

Clinical results using the OCUVANE® eyelid wipes

OCUVANE® eyelid wipes to treat dry eye complaints

In a clinical study in which all patients developed dry eye complaints at baseline, 35% of patients had complete resolution of dry eye complaints after 1 month of treatment. After one-daily treatment for 1 month, 98% of patients reported a clinically significant improvement after treatment, with the rate of improvement increasing in proportion to the severity of the disease. The results showed that the stability of the tear film was significantly improved after 1 month of treatment. In addition, dirt and mucus deposited on the eyelids, eyelid inflammation, Demodex infection, and redness of the eye were significantly reduced. After 1 month of treatment, ⅔ of the patients showed significant improvement in at least 3 of the studied parameters. The method of treatment was rated as good by 75% of patients and effectiveness of treatment by 75% as very good.
At the end of the study, all patients, without exception, reported that their eyes felt fresher than before, both during the day and during computer screen use.

OCUVANE® eyelid wipes to reduce bacterial infection

In a clinical study, a single wipe of the eyelids with OCUVANE® eyelid wipes significantly reduced the number of pathogens (colony forming unit – CFU) living on the conjunctiva.

Safety of the treatment

In clinical studies, there were no side effects reported by patients during, or immediately after the application of the treatment. At the end of the study there were no reported complaints associated with the treatment.